Postsynaptic dopamine (D2)-mediated behavioural effects of high acute doses of artemisinin in rodents

Brain Research Bulletin

Volumn 62, Issue 3, 2003, Pages 255-260

  Amos, S ^a   Chindo, B A ^a   Abbah, J ^a   Vongtau, H O ^a   Edmond, I ^a   Binda, L ^a   Akah, P A ^a   Wambebe, C ^a   Gamaniel, K S ^a  

^a NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

Author keywords

Apomorphine; Artemisinin; Behavior; Bromocriptine; Locomotor activity

Indexed keywords

APOMORPHINE; ARTEMISININ; BROMOCRIPTINE; DOPAMINE 2 RECEPTOR; PENTOBARBITAL; RESERPINE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; EXPLORATORY BEHAVIOR; HYPERACTIVITY; LOCOMOTION; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SLEEP; STEREOTYPY;

EID: 0347123262     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2003.09.016     Document Type: Article

References (32)

1. Amos S., Kolawole E., Akah P., Wambebe C., Gamaniel K. Behavioural effects of the aqueous extract of Guiera senegalensis in mice and rats. Phytomedicine. 8(5):2001;356-361.
2. 1 receptor agonist SRF 38393. J. Pharmacol. 41:1989;490.
3. Augustine P.A., D'Hulst J.V.D., Kinget R. Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells. J. Pharm. Sci. 85:1996;577-579.
4. K. Bone, M. Morgan, Clinical Application of Ayuverdic and Chinese Herbs: Monographs for the Western Herbal Practitioner, Phytotherapy Press, Wardick, Australia, 1992, pp. 7-12.
5. 2 subtypes of dopamine receptors in rat brain, J. Neurosci. 6 (1986) 3177.
6. Bruce-Chwatt, Chemotherapy of Malaria, second ed., World Health Organization, Geneva, 1981, p. 104.
7. R. Carpenedo, A. Chiarugi, O. Russi, G. Lombardi, V. Carla, R. Petticciari, et al., Inhibitors of kynuremine hydroxylase and kynureniase increase cerebral formation of kynurenate and have sedative and anti-convulsant activities, Neuroscience, 1994.
8. 2 dopamine receptors in the human brain. Neurosci. Lett. 91:1988;142.
9. Ferre S.M., Herrera-Marschitz M., Grabowska-Andien M., Cassa U., Ungerstedt U., Andin N.E. Postsynaptic dopamine/adenosine interaction. II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short term reserpinised mice. Eur. J. Pharmacol. 192:1991;31.
10. File S.E. Effect of chlorpromazine on exploration and habitation in rat. Br. J. Pharmacol. 49:1973;303-310.
11. File S.E., Fernandes C. Dizocilipine prevents the development of tolerance to the sedative effects of diazepam in rats. Pharmacol. Biochem. Behav. 47:1994;823-826.
12. File S., Pellow S. The effect of triazolobenzodiazepines in two animal tests of anxiety and on the hole-board. Br. J. Pharmacol. 86:1985;729-735.
13. Genovese R.F., Newman D.B., Gordon K.A., Brewer T.G. Acute high dose arteether toxicity in rats. Neurotoxicology. 20(5):1999;851-859.
14. Genovese R.F., Newman D.B., Petra's J.M., Brewer T.G. Behavioural and neural toxicity of arteether in rats. Pharmacol. Biochem. Behav. 60:1998;449-458.
15. Hien T.T., White N.J. Qinghaosu. Lancet. 341:1993;603-608. (review).
16. Kenneth S.K., Kenneth I.D. Genetic control of apomorphine-induced climbing behavior in two inbred mouse strains. Brain Res. 293:1984;343-351.
17. Klayman D.L. Qinghaosu (artemisinin). An antimalarial drug from China. Science. 228:1985;1049-1054.
18. Mansur J., Martz R.M.W., Carlinin E.A. Effects of acute and chronic administration of Cannabis satis and (-)-9-trans-tetrahydro cannabinol on the behavior of rats in open field arena. Psychopharmacology. 19:1971;338-397.
19. T.S. Miya, H.G.O. Holck, G.K.W. Yim, G.R. Spratto, Laboratory Guide in Pharmacology, Burgess Publishing Co., Minneapolis, MN, 1973, pp. 44-46.
20. N'Gouemo P., Nguemby-bina C., Baldt-Moulinier M. Some neuropharmacology effects of an ethanolic extract of Maprounea africana in rodents. J. Ethnopharmaol. 43:1994;161-166.
21. Ozturk Y., Aydin S., Beis R., Baser K.H., Berberoglu H. Effects of Hypericum perforatum L. and Hypericum calycinum L. extracts on the central nervous system in mice. Phytomedicine. 3:1996;139-146.
22. Perez R.M.G., Perez J.A.L., Garcia L.M.D., Sossa H.M. Neuropharmacological activity of Solarium nigrum fruit. J. Ethnopharmacol. 62:1998;43-48.
23. Phillipson J.D., Wright C.W. Can Ethnopharmacology contribute to the development of antimalarial agents? J. Ethnopharmacol. 32:1991;155-165.
24. Salomone J.D. Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes. Psychopharmacology. 107:1991;160-174.
25. Schultz W. Depletion of dopamine in the striatum as an experimental model of Parkinsonism: direct effects and adaptive mechanisms. Prog. Neurobiol. 18:1982;121.
26. Speroni E., Minghetti A. Neuropharmacological activity of extracts from Passifora incarneta. Planta Med. 54:1998;488-491.
27. Stolk J.M., Rech R.H. Antagonism of O-amphetamine by methyl-p-tyrosine. Behavioural evidence for participation of cathecolamine stores and synthesis in the amphetamine stimulant response. Neuropharmacology. 9:1970;249-263.
28. W. Tang, G. Eisen Brand, Chinese Drugs of Plant Origin, Springer-Verlag, Berlin, 1992, pp. 160-174.
29. U. Ungerstedt, Central dopamine mechanisms and unconditional behavior, in: A.S.J. Korf, B.H.C. Westernik (Eds.), The Neurobiology of Dopamine, Academic Press, London, New York and San Francisco, 1979, p. 577.
30. Wambebe C. Influence of some agents that affect 5HT metabolism and receptors and nitrazepam-induced sleep time in mice. Br. J. Pharmacol. 84:1985;191.
31. D.P. Westfall, Antihypertensive drugs: drugs that interfere with noradrenergic storage, in: C.R. Graig, R.E. Stiltzel (Eds.), Modern Pharmacology, fourth ed., Little, Brown and Company, New York, 1994, pp. 229-248.
32. Wolfman C., Viola H., Paladini A.C., Dajas D., Medina J.H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coeruiea. Pharmacol. Biochem. Behav. 47:1994;1-4.